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Chapter 7
Psycho-cognitive Factors Orienting 
eHealth Development and Evaluation
Alessandra Gorini, Enrico Gianluca Caiani, and Gabriella Pravettoni
1  The P5 and the Personomics Approach
“Individuality of human beings affects predisposition to disease and response to 
treatment” (Potter, 1988; Sykiotis, Kalliolias, & Papavassiliou, 2005), stated 
Hippocrates in the fifth century BC, becoming the first known physician mentioning 
the relevance of a personalized approach to diagnosis and treatment. Many centuries 
later, personalized medicine has gained increasing attention (Britten, Pope, Halford, 
& Richeldi, 2016; Brownell et al., 2016), applying the Hippocratian vision to the 
need of “delivering the right treatment to the right patient at the right time” (MRC, 
2017) (cf. Chap. 4).
Starting from the individuality of human beings—and to further enrich the per-
sonalized medicine approach—that is mainly based on the biological characteriza-
tion of each individual, some years ago we proposed the P5 approach (Gorini & 
Pravettoni, 2011; Pravettoni & Gorini, 2011). The fifth P (that followed the other 
four P’s: predictive, personalized, preventive, and participatory (Hood & Friend, 
2011)) indicated the psycho-cognitive aspects that characterize a patient not only as 
a biological and genetic entity, but also as a person with specific needs and values, 
habits and behaviors, hopes and fears, beliefs, personality, and cognitive disposi-
tions. Introducing the fifth P, we underlined the need of integrating all these aspects 
with biological and genetic information in order to empower the patient, increase 
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his/her quality of life (QOL) and transform him/her from a passive recipient of care 
into an active decision-maker during the entire treatment process (Joseph-Williams, 
Elwyn & Edwards, 2014) (cfr. Chap. 1).
In line with this patient-centered approach, a few years later, the term “per-
sonomics” was introduced (Ziegelstein, 2015). Inspired by the other “-omics,” 
including genomics, proteomics, metabolomics, epigenomics, and pharmacoge-
nomics, created to characterize patients by their biological uniqueness and to pro-
vide more precisely tailored diagnostics and therapeutics, personomics refers to the 
patient’s unique psychosocial situation and life circumstances that may alter disease 
behavior and response to treatment (Ziegelstein, 2015). In accordance with the pre-
vious P5 approach, personomics distinguishes individuals not only by their biologi-
cal variability, but also by their psychological characteristics, health beliefs, social 
support networks, education, socioeconomic status, health literacy, and all the other 
life conditions and events that may have important consequences on when and how 
a certain health condition will manifest in that individual and how it will respond to 
treatment (Ziegelstein, 2015). As the other -omics, these individual characteristics 
are critical to patient care, being useful for a better understanding of the pathogen-
esis and treatment of disease and allowing a more personalized care that takes into 
account the patient’s internal world and external life circumstances.
By embracing the P5 and the personomics approaches, non-pharmacological 
interventions, including, among others, psychological support, a greater involve-
ment of patients in shared decision making, and lifestyle coaching, appear to be 
relevant to reinforce the effects induced by traditional pharmacological treatments. 
Assessing the individual needs and perspectives, together with the patient’s psycho-
logical attitudes and preferences may be also relevant to improve his/her treatment 
adherence, satisfaction, and, overall, his or her short- and long-term quality of life. 
Moreover, since such personal characteristics can change over time, or because of 
the presence of an illness or, again, its progression or recovery, an iterative evalua-
tion of the individual patient may become a key feature for an effective personalized 
disease management (cfr. Chap. 3).
In traditional care paradigms, patients are physically evaluated when the diagno-
sis is established, and, only when necessary, at one or more follow-ups. Sometimes, 
psychological and/or quality of life evaluations are also performed depending on the 
patient’s illness and local guidelines. Nevertheless, such evaluations, when present, 
are not sufficient to guarantee the right attention to the above individual factors and 
do not allow a long-term monitoring of the patient’s characteristics and evolution. 
Moreover, time and cost constraints, other than patients’ limitations and difficulties, 
prevent the application of the P5 approach in the actual clinical practice.
According to the P5 and the personomics approaches, collecting organized 
patient’s input throughout the entire disease course is important for different 
reasons:
• To correlate psychological variables and quality of life with physical events, 
clinical state, and clinical recurrences
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• To better respect the patient’s needs and preferences to not lose treatment 
adherence
• To provide better tailored treatments
• To maintain a contact with patients during and after recovery
• To empower patients in improving their understanding of their health conditions 
and in making them actively involved in the management of their own disease
2  The Key Elements for the P5-Personomics Approach
What are the key elements of the P5-personomics approach and how can they be 
collected? Which instruments can be used by physicians to understand the patient as 
an individual?
The National Institute for Health and Clinical Excellence (NICE) has proposed a 
guideline document ((UK), 2012) that outlines 5 areas containing the elements of 
knowing the (adult) patient as an individual (p. 48). These areas include the consid-
eration of:
 1. How clinical conditions affect the person and how the person’s situations and 
experiences affect his/her condition and treatment.
 2. How the patient’s life circumstances affect his/her treatment involvement and 
experiences, and his/her lifestyle choices.
 3. How the patient’s concerns, values, and preferences affect the way he/she 
engages with the treatment experience.
 4. How the patient’s psychological, social, spiritual needs affect his/her condition 
and treatment.
 5. They also include an admonition to clinicians not to make assumptions about the 
patient based on appearance.
To answer the second question as to how such information can be collected, the 
most intuitive solution would be to interview each patient for as much time as pos-
sible. Unfortunately, this is not a feasible solution in the everyday clinical practice 
for the following reasons:
• Physicians have not enough time to investigate such aspects.
• Collecting this information requires different methods compared to those used to 
investigate medical symptoms.
• One single interview is not sufficient to implement a new model of cure based on 
the P5 approach.
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3  Solutions Come from the eHealth Apps
A very promising approach to solve the above limitations and to collect as much 
data as possible involving patients in managing their health comes from eHealth. 
eHealth solutions have been considered in the last two decades as the “holy grail,” 
able (if properly implemented and scaled up) to reduce healthcare costs (cfr. 
Chap. 1), and improve patient experience while maintaining adequate levels of care 
(Tang and Lansky 2005; Bradford & Palmer 2016) (cfr. Chap. 4). In particular, 
eHealth solutions provide the basis for “participatory health” (cfr. Chap. 6), in 
which active involvement of all the involved parties—the patient, caregivers, and 
healthcare professionals alike—is encouraged. This assumes particular importance 
in the context of searching for innovative ways of supporting chronic patients, 
where it is fundamental to keep under control the underlying pathology and detect 
as early as possible the signs of worsening in order to anticipate countermeasures 
and prevent possible hospitalization. Thanks to the developments in the field of 
information and communication technology (ICT) observed in the last years, in 
particular with the large penetration of mobile cellular phone technology in the 
global market and its ubiquitous access to the World Wide Web, a large proportion 
of the world population has now access to and uses the Internet in their daily lives 
(via, e.g., a PC, tablet, wearables, and/or smartphone), thus finally providing the 
tools for the “holy grail” to exploit its potentials within healthcare (Internet World 
Stats, 2018; Kay et al., 2011).
This technologically permeated background, if properly utilized in the context of 
clinical medicine, has the potential to switch the way healthcare is provided from a 
paternalistic model to a collaborative approach, by means of self-management, 
shared decision making, and a coaching relation between the physician and the 
patient (Mead and Bower, 2000; Bacigalupe & Askari, 2013) (cfr. Chap. 4). In this 
way, the focus of healthcare could be moved from management of acute episodes to 
secondary prevention, and also to primary prevention (cfr. Chap. 3), physical fit-
ness, nutrition, mental health, end-of-life care, home-care, and other fields related to 
an individual’s health.
4  Digital Health in the Patient’s Journey
Indeed, the use of technology for health is already permeating the patient journey, 
from prevention to treatment: while there are no diseases, access to specific tools 
such as mobile applications (or “apps”) could increase knowledge about possible 
risks associated to incorrect lifestyle behaviors and help in increasing levels of well-
ness through self-monitoring of exercise and fitness, diet and nutrition, alcohol 
moderation, and smoking cessation.
Once symptoms of a disease are manifested, a plethora of patient experience 
tools are available: searching related keywords on the web, specific apps for symp-
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tom checking, social media to share concerns, and tools to find specialized centers 
if necessary.
In the process of clinical decision making, the physician could base the diagnosis 
on data acquired directly by the patient using smartphone embedded sensors or con-
nected medical devices that have the potential to record possible pathologic phe-
nomena when they manifested, if symptomatic (e.g., for atrial fibrillation (Halcox 
et al., 2017), thus overcoming some existing limitations of well-established diag-
nostic Holter ECG technology).
Once the diagnosis has been established, the physician may recommend digital 
tools for condition monitoring, such as app-supported disease management pro-
grams, connected sensors for remote monitoring and rehabilitation programs, or 
apps for psychological and cognitive profiling, and for any use case across the 
patient journey. In addition, patients could share their experiences, success and fail-
ure stories in patient’s forum groups specific for the underlying pathology. In the 
context of treatment, medication management and adherence could be improved by 
utilizing digital tools, from simple reminders activated through the smartphone to 
more advanced electronic medication packaging (EMP), or solutions based on 
active patient involvement and artificial intelligence.
4.1  A Possible Scenario
Taking into account the P5 approach, such tools could be perhaps structured on the 
basis of the NICE guidelines, to be used by the patient both during the acute and the 
chronic phase of the illness. Organized in different areas, they can be used to:
 1. Fill health journal, allowing users to record their clinical parameters directly or 
from remote monitoring tools.
 2. Write diaries of life events that can have a significant impact on the individual 
well-being and quality of life. They include negative or stressful events occur-
ring in everyday working or personal life, health-related events, illness recur-
rences, and any kind of event that is perceived as negative by the individual.
 3. Collect the patient’s concerns about the treatment experience, such as treatment 
side effects, or patient’s complaints including physical or behavioral aspects 
induced by treatments.
 4. Regularly collect information about the patient’s social conditions and psycho-
logical status. Individual characteristics, such as personality traits, decision- 
making style, emotional profile, as well psychological dimensions, such as the 
presence of stress, anxiety, depression, etc, and the presence of protective or 
negative social conditions (social support or social isolation, etc.) are collected 
in this area.
All this information may be collected through monitoring tools and periodic 
remote administrations of specific questionnaires starting from the acute phase of 
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the illness (if possible) for as long a time as possible in order to provide long-term 
monitoring of the patient, from the acute to the chronic phase.
Specific algorithms are then needed to put together information obtained from 
the different areas in order to integrate physical, environmental, and psychological 
factors into explanatory and possibly predictive models.
At the same time, periodic reports for patients and physicians may be created by 
the system in order to make the patient aware of his/her condition and to alert the 
physicians when unexpected or worrying events or health changes occur.
A comprehensive monitoring program, consisting of an eHealth app collecting 
different patient information may have the potential to improve trial design, enhance 
self-management, allow for early treatment adaption to minimize side effects, 
reduce hospital admissions, and, in general, improve personalized management and 
long-term QOL. Only by integrating biological information with patient-reported 
and patient-collected information, will we be able to realize truly personalized treat-
ment, preventing clinicians from making assumptions about the patient based on 
appearance, as suggested by the fifth point of the NICE guidelines.
5  The Importance of Patient Education
Due to the availability of medical information through an incredible number of 
sources, a deep cultural change has been manifested, and described by the term of 
apomediation (Eysenbach, 2008) that is  the process of disintermediation, where 
previous intermediaries (e.g., healthcare professionals) are functionally bypassed 
by new apomediaries (i.e., the web, online groups, GoogleSearch, etc.) in guiding 
the citizens’ access to health information.
To appreciate the relevance of this phenomenon, this open access to information 
through technology could be compared to what happened after the introduction of 
movable-type printing press by Gutenberg in 1439, which led later to the era of 
mass communication in Renaissance Europe. This invention, by increasing literacy, 
permanently altered the structure of the society by the relatively unrestricted circu-
lation of information and revolutionary ideas, thus threatening the power of political 
and religious authorities and breaking the education and learning monopoly of the 
literate elite, thereby bolstering the emerging middle class.
In the medical information context, while increasing patient literacy is a positive 
factor, the chief ethical concern regarding apomediation is that incorrect ideas or 
potentially dangerous practices will take hold. As observed previously, patient edu-
cation is a lifelong program, where technology can enhance the learning process, 
but reliable content is the key. Examples of possible consequences related to these 
cultural changes are represented by the information overload while searching infor-
mation through Internet (e.g., 770 million results are returned by Google when 
searching for “cancer” and 389 million when searching for “diabetes”), or by the 
incredible proliferation of apps in the “Medical” and “Health & Fitness” categories 
in the app stores: the patient is potentially left alone in the process of choosing 
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which information to rely on, or which app to adopt that best suits her/his needs, 
with the risk of trusting unreliable sources or using apps with claims not supported 
by validation for accuracy and efficacy.
In the process of patient empowerment, defined as the acquisition of motivation and 
ability that patients might use to be involved or participate in decision making (Fumagalli 
et al., 2015), patient education becomes a critical goal for patient enablement, that is, 
the acquisition of knowledge and skills for meaningful self-management.
Patient education aims to increase the level of health literacy, defined as the abil-
ity of the patient to obtain, read, understand, and use healthcare information to make 
appropriate health decisions and follow instructions for treatment and self-care 
(Sørensen, et  al., 2012; Mårtensson and Hensing, 2012). Indeed, patient literacy 
constitutes the first step to properly understand health concepts, and it has been 
indicated by the World Health Organization as one of the social and economic fac-
tors impacting on adherence, defined as the extent to which the persons’ behavior 
corresponds with agreed recommendations from a healthcare provider (Adherence 
to long-term therapies. Evidence for action, WHO 2003). To effectively utilize 
mHealth technology, health literacy is not enough, as digital literacy, that is, the 
ability to locate, organize, understand, evaluate, and analyze information using digi-
tal technology, needs to be ensured. These two abilities have been lately summa-
rized in the concept of digital health (eHealth) literacy as the ability to seek, find, 
understand, and appraise health information from electronic sources and apply the 
knowledge gained to addressing or solving a health problem (Norman and Skinner, 
2006). As a recent EU-funded project (Health Literacy Europe) has highlighted, 
health literacy cannot be taken for granted as, of the eight countries (Austria, 
Bulgaria, Germany, Greece, Ireland, the Netherlands, Poland, Spain) surveyed, only 
the Netherlands showed less than 40% of the studied population with inadequate or 
problematic levels, while the other countries had higher values, with extremes found 
in Spain (58.5%) and Bulgaria (62.1%).
Considering that the main cause of medical errors have been attributed to 
communication- related origins (Hughes and Ortiz, 2005), the ability of the patient 
to fully understand medical recommendations given by the physician during the 
consultation appears crucial: in Kessels (2003) it was reported that from the given 
medical information, 40–80% is immediately forgotten, while half retained is incor-
rect. To improve physician–patient communication, the teach-back assessment has 
been proposed as a method to confirm patient’s understanding of medication and 
treatment recommendations (Porter et al., 2016). In this context, digital technolo-
gies provide new opportunities also for physicians to get used to this approach, with 
online learning modules freely available through the Internet (Abrams et al., 2012) 
or for the patient, with video recorded outpatient clinic sessions accessible for the 
patient via patient portal, as recently implemented at the Erasmus Medical Center in 
Rotterdam.
In order to define the baseline level for comparison after exposure to the educa-
tional interventions to determine its effectiveness, it is important to assess patient 
health literacy. In literature, different assessment tools have been proposed; for 
example, the Rapid Estimate of Adult Literacy in Medicine (REALM) (Davis et al., 
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1993), or the Test of Functional Health Literacy in Adults (TOHFLA) (Parker et al., 
1995), designed to measure both reading comprehension and numeracy to assess 
adult literacy in the healthcare setting. In the context of eHealth and health infor-
matics for patients or for the public, it is crucial to be aware of who the final user 
really is and what characteristics he/she has that might impact on eHealth design 
and implementation: digital health (eHealth) literacy needs to be assessed. The 
foundations of the eHealth literacy concept are based in part on social cognitive and 
self-efficacy theories, which promote competencies and confidence as precursors to 
behavior change and skill development. eHealth literacy includes six core skills, or 
literacies: (1) traditional literacy; (2) health literacy; (3) information literacy; (4) 
scientific literacy; (5) media literacy; (6) computer literacy. The eHealth Literacy 
Scale (eHEALS) is a self-report tool composed of eight questions that can be 
administered by a health professional and is based on an individual’s perception of 
his/her own skills and knowledge within each measured domain (Norman and 
Skinner, 2006).
6  Persuasive Design Technology
Research has proven that by means of technology, it is possible to help people to 
change their thoughts, improve their behavior and gain better health and well-being. 
Cognitive behavior psychology aims to explain, predict, and change our behavior 
using processes that are going on in the mind. In 1958, Albert Ellis developed one 
of the first cognitive behavior theories explaining how and what kind of cognitions 
(i.e., beliefs and thoughts) can change behavior. Since then, several theories for 
behavior change have been developed, thus prescribing what factors must be first 
influenced.
Behavior change is about persuasion, therefore behavior change techniques are 
often persuasive strategies as well. In the last decades, technology is used more and 
more as a vehicle for persuasion, because of its interactivity and adaptability. 
Compared to human persuasion, technology solutions present several advantages:
• Persistence: technology does not get tired of trying to persuade someone, and it 
can continue indefinitely.
• Anonymity: when talking to a human persuader, it is impossible to stay anony-
mous, while with technology this is easier, thus representing a huge advantage 
for sensitive subjects (i.e., psychological problems or substance abuse).
• Ability to manage large volumes of data: technology’s ability to process huge 
volumes of data in a short time gives more persuasive power, as technology can 
back up a certain message with the data that supports it.
• Scalability: people can only reach a limited number of other people; using tech-
nology, many more people can be reached without a large increase in cost.
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• Ubiquity: technology can be everywhere, even in places where a human per-
suader cannot be allowed to be. As for many behavior change techniques, effec-
tive timing of message delivering is crucial, so ubiquity represents a pivotal 
characteristic to modify existing behaviours;
• Multimodality: technology can present information in many different ways, 
including text, audio, and video, thus matching each person’s individual prefer-
ences to the persuasive methods it uses.
In the late 1990s, the use of technology to persuade the users to change their 
behavior was first defined by Fogg (2002), and more recently persuasive systems 
were defined as “computerized software or information systems designed to rein-
force, change or shape attitudes or behaviours or both without using coercion or 
deception” (Oinas-Kukkonen and Harjumaa 2018).
Technology can act in persuading throughout several different techniques:
• Informing: individuals have to learn the presented information, in order for this 
information to be remembered.
• Reinforcement: desired behaviour should be rewarded/reinforced as quickly as 
possible upon its performance.
• Discussing: individuals share their thinking processes and beliefs among each 
other.
• Social comparison: individuals are stimulated to compare themselves with indi-
viduals from other groups that perform the desirable behavior.
• Fear appeal: materials (i.e., images or texts that elicit fear) are presented and 
should appeal fear to individuals of the target group; typically, fear appeals are 
effective to a certain extent only, because, when reaching a high level of elicited 
fear, target users could avoid the issue instead of considering it.
• Skills training: individuals learn from practicing behavior by themselves, and 
practice improves their confidence.
In the context of the P5 approach, by using the persuasive power of technology, 
eHealth solutions can be made more effective, as people are more adherent to 
eHealth interventions when more persuasive elements are used (Kelders & Van 
Gemert-Pijnen, 2013). The Persuasive System Design (PSD) model (Oinas- 
Kukkonen and Harjumaa 2018) represents a state-of-the-art approach for designing 
and evaluating persuasive systems. It is applicable to systems that are designed to 
form, alter, or reinforce attitudes, behaviors, or an act of compliance without using 
deception, coercion, or inducements, that is, it is well suited for the design of 
eHealth technologies.
The PSD model assumes several principles common to all persuasive systems, as 
regards the ways that people can be persuaded by means of technology:
• Technology is never neutral, but has always an intention.
• People like their views and behavior to be organized and consistent: if systems 
support the making of commitments, then users are more likely to be persuaded 
to follow these commitments.
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• Persuasion is often incremental: behavior change never takes place at once, but 
in small steps.
• Direct and indirect routes: paying attention (consciously or unconsciously) is 
very important when changing behavior.
As regards the characteristics that a technology should have in order to effec-
tively persuade people, these can be listed as:
• Unobtrusive, to fit into our daily lives without requiring a big change in our daily 
routines.
• Open, to allow a person that starts using a system to clearly know its purpose 
from the beginning.
• User-friendly, as a system is more effective when it is appealing and easy-to-use; 
however, recent approaches partially challenged this assumption, because even 
tools difficult to use could generate emotions and affection that influence both 
their usage and their persuasive power (cfr. Chap. 9).
The PSD model defines four categories of elements, or software features, based 
on what technology can do to persuade its users into changing their attitude or 
behavior: (1) primary task support; (2) dialogue support; (3) credibility support; (4) 
social support. Accordingly, different software features based on psychological 
theories can be chosen and implemented to reach the aim of supporting the user’s 
primary activities, to facilitate the information flow between the computer and the 
user, to increase credibility about the presented information, or to leverage social 
influence.
In recent years, the PSD has been used both to better understand the impact of 
persuasive eHealth technology, as well as to evaluate which features are imple-
mented in an eHealth solution, and their effects on adherence and outcome. It rep-
resents a promising field in the aim of changing behavior in the domain of health 
and well-being, but more studies are needed to get more insight into which features 
and subjective factors could predict the effectiveness of eHealth technology.
Once these aspects are better defined, it will be possible to define an optimal inter-
vention for each individual, based on the selection of only those software features 
able to highly engage the subject. This could then be described by extending the P5 
approach with a sixth “p” relevant to “persuasive,” to describe the personalized pro-
cess of defining a specific persuasive technology approach that could optimize the 
desired change in behavior, paving the way for a P6 approach conceptualization.
7  Conclusion
In this chapter, we have seen how eHealth could be based on a more accurate and 
systematic consideration of the psycho-cognitive uniqueness of individuals (and 
patients). Specifically, we have presented persuasive technology as a possible 
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resource for designing technologies able to promote treatment adherence and 
healthy activities (e.g., behavioral change regarding lifestyle); however, we have to 
consider that medicine in general is a still evolving field. Although we have dis-
cussed that a consideration of psychological aspects is fundamental for the health-
care context to evolve toward patient centeredness, the research is still open to a 
complete understanding of the psycho-cognitive aspects to be included in the design 
and evaluation of technologies.
Future studies may focus on how technologies can help patients to perform deci-
sions toward their healthcare process, by identifying the influence of biases and 
misconceptions that could lead patients toward making disadvantageous choices 
toward their own health management; such technologies could be used not only to 
aid medical practice (Lucchiari, Folgieri & Pravettoni, 2014), but also to empower 
patients (Woltmann et  al., 2011); moreover, cognitive psychology would be 
included, in the form of theory-based prescriptions, in user-centered design 
approaches toward the development of health technologies, in order to take into 
consideration patients’ mindset and cognitive abilities.
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